Most Recent
With its ‘significant’ reputation, IMDb wins challenge to Zumedia trade mark
Intellectual Property 2025-06-24 11:25 pm By Sam Matthews

Movie database giant IMDb has won a stoush with media company Zumedia, with IP Australia finding Zumedia’s ‘DMDb’ trade mark was likely to cause confusion.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Element Zero to fight Fortescue’s bid for 9M docs seized under search order
Intellectual Property 2025-06-19 11:32 pm By Sam Matthews

Green iron start-up Element Zero has said it will fight Fortescue’s bid to access nearly nine million documents collected under a controversial search order in the mining giant’s case alleging former employees misappropriated its process for carbon dioxide-free iron. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sandoz says Amgen ‘dragging the chain’ in fight over bone drug biosimilar
Intellectual Property 2025-05-15 11:06 pm By Andy Sidler

Sandoz has accused Amgen of ‘dragging the chain’ as the Swiss biotech continues to mull whether to launch infringement proceedings over six patents for its Prolia and Xgeve bone disease biologics.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sandoz moves to block Amgen’s attorneys from prosecuting patents in IP spat
Intellectual Property 2025-05-06 11:41 pm By Andy Sidler

Generic drug maker Sandoz wants to shield information turned up by preliminary discovery orders from the eyes of Amgen patent attorneys in a spat over cheap versions of Amgen’s bone disease drugs, and says if they view the material they should be barred from prosecuting future related patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘Further or in the alternative’ no problem in bovine gene patent suit: court
Intellectual Property 2025-04-08 11:23 pm By Sam Matthews

A group of Australia’s leading beef and dairy companies has failed to strike-out a suit alleging their genetic testing system for cattle infringes the patent of a US genomics company, with a judge rejecting objections to the phrase ‘further or in the alternative’.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis loses appeal over patent for heart drug Entresto
Intellectual Property 2025-03-24 11:50 pm By Cat Fredenburgh

Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Element Zero loses appeal of search orders in Fortescue trade secrets case
Intellectual Property 2025-03-14 11:42 pm By Cindy Cameronne

Green iron start-up Element Zero has lost its latest bid to set aside search orders in a case by Fortescue alleging former employees misappropriated its process for carbon dioxide-free iron. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Otsuka appeals win for Sun Pharma over injectable Abilify patent
Intellectual Property 2025-03-03 11:50 pm By Christine Caulfield

Otsuka Pharmaceuticals is challenging a decision revoking its patent for an injectable version of antipsychotic drug Abilify.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Court invalidates Otsuka’s patent for injectable Abilify
Intellectual Property 2025-02-13 11:27 pm By Sam Matthews

Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker’s top-selling antipsychotic Abilify.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis appeals IP win for Pharmacor over blood pressure drug
Appeals 2025-01-20 11:42 pm By Christine Caulfield

Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?